0      0

2022 uroLogic Conference

273 - Focal Therapy for Prostate Cancer


Oct 1, 2022 2:50pm ‐ Oct 1, 2022 3:50pm



Credits: None available.

Members: $20.00
Standard: $30.00

Description

Focal therapy of prostate cancer is becoming an increasingly popular treatment of localized disease aimed at minimizing the detrimental impact on quality of life. This talk provides an overview of focal therapy treatment options, candidate identification, and how patients are followed after focal therapy.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 10/2/24.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:

Hillary Durstein, MSN, APRN, NP-C, CUNP discloses that she is a speaker for Hollister and Cardinal Health.

There are no other Planning Committee disclosures to declare.

Speaker Disclosures:
Kelly Stratton, MD, FACS discloses that he has clinical trial agreements with Pfizer, Inc. and EMD Serono; is a speaker for Arkansas Urology; and provides professional services for Janssen Pharmaceuticals, Inc., Alliance Health Ponca City Medical Center, Ebix, Inc., and Merck & Company, Inc.

There are no other speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the participant will be able to describe the different focal therapy treatment options available for patients with prostate cancer.

Speaker(s):

  • Kelly Stratton, MD, FACS, Associate Professor, University of Oklahoma Health and Sciences

Credits Available


Focal Therapy for Prostate Cancer

You must be logged in and own this session in order to post comments.